The latest pharma & life science accounting and reporting developments
Pharmaceutical and life sciences companies must consider a wide range of emerging risks as they adapt their business practices to changing regulatory compliance and market-driven pressures. Some of these include globalization, the advancement of technology and expanding stakeholder expectations. Risks are no longer confined to discrete areas and functions within organizations. From regulatory pressures to consumer demands for increased transparency, organizations are increasingly seeking total solutions. New information systems, strategies, and processes to manage compliance are rapidly evolving in response to these pressures.
Pharmaceutical and life sciences companies around the world are facing pressure to develop more effective tax strategies while remaining compliant in a constantly changing regulatory landscape. Tax concerns impact a wide range of areas that include research and development credits, transfer pricing, state and local planning, and more.